Covaxin to be Evaluated as COVID-19 Vaccine in US, Say Sources

Covaxin, India's COVID-19 vaccine, is to be evaluated as a vaccine candidate in the United States, said Bharat Biotech.

Covaxin, India’s COVID-19 vaccine, is to be evaluated as a vaccine candidate in the United States, said Bharat Biotech.

"Covaxin will be evaluated as a Covid-19 vaccine candidate in the United States. US biotech company Ocugen announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the company’s Investigational New Drug Application (IND) to evaluate the Covid-19 vaccine candidate, BBV152, known as Covaxin outside the United States," the Hyderabad-based vaccine manufacturer said in a statement.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘Covaxin is India's indigenous Covid-19 vaccine manufactured by Bharat Biotech, which has been developed in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV).’

Ocugen is co-developing Bharat Biotech’s Covaxin vaccine candidate for Covid-19 in the US and Canada.

Covaxin is one of the two vaccines which is being administered mainly in India.

Covaxin has already been granted Emergency Use Listing (EUL) in 13 countries so far, according to the World Health Organization.

Third Covaxin Dose Safe, Effective, says ICMR
The Indian Council of Medical Research said the third dose of Covaxin holds promise a day before the government plans to provide COVID-19 vaccines to frontline, healthcare workers and senior citizens with co-morbidities.

It was given emergency use approval by the Drugs Controller General of India (DCGI) for the 12–18 age group on December 24, 2021.

Source-IANS

Painkillers Not Recommended After Getting Covaxin Vaccination
No painkillers or Paracetamol are recommended for teenagers after being vaccinated with Covaxin, said vaccine maker Bharat Biotech.

Covaxin for Children Proven to be Safe in Phase II/III Study
Covaxin was proven to be safe, well-tolerated, in children who took part in phase II/III study.